| Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models C Belgiovine, E Bello, M Liguori, I Craparotta, L Mannarino, L Paracchini, ... British journal of cancer 117 (5), 628-638, 2017 | 135 | 2017 |
| DNA Damage Response and Immune Defense C Nastasi, L Mannarino, M D’Incalci International Journal of Molecular Sciences 21 (20), 7504, 2020 | 77 | 2020 |
| Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective … M Petrillo, GF Zannoni, L Beltrame, E Martinelli, A DiFeo, L Paracchini, ... Annals of Oncology 27 (4), 625-634, 2016 | 72 | 2016 |
| The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 M Liguori, E Digifico, A Vacchini, R Avigni, FS Colombo, EM Borroni, ... Cellular & Molecular Immunology 18 (3), 711-722, 2021 | 70 | 2021 |
| lncRNAs as novel indicators of patients' prognosis in stage I epithelial ovarian cancer: A retrospective and multicentric study P Martini, L Paracchini, G Caratti, M Mello-Grand, R Fruscio, L Beltrame, ... Clinical Cancer Research 23 (9), 2356-2366, 2017 | 66 | 2017 |
| Tumor immune microenvironment and genetic alterations in mesothelioma S Hiltbrunner, L Mannarino, MB Kirschner, I Opitz, A Rigutto, A Laure, ... Frontiers in oncology 11, 660039, 2021 | 33 | 2021 |
| Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies L Paracchini, L Mannarino, I Craparotta, C Romualdi, R Fruscio, T Grassi, ... Oncotarget 12 (24), 2404, 2021 | 28 | 2021 |
| Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms M Romano, MG Della Porta, A Gallì, N Panini, SA Licandro, E Bello, ... British journal of cancer 116 (3), 335-343, 2017 | 26 | 2017 |
| Multisite analysis of high‐grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26. 2 and 8q24. 3 S Ballabio, I Craparotta, L Paracchini, L Mannarino, S Corso, MG Pezzotta, ... International journal of cancer 145 (10), 2670-2681, 2019 | 23 | 2019 |
| Combination of PPARγ agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas R Frapolli, E Bello, M Ponzo, I Craparotta, L Mannarino, S Ballabio, ... Clinical Cancer Research 25 (24), 7565-7575, 2019 | 20 | 2019 |
| Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study L Mannarino, L Paracchini, F Pezzuto, GE Olteanu, L Moracci, L Vedovelli, ... International Journal of Molecular Sciences 23 (10), 5786, 2022 | 12 | 2022 |
| Is DNA repair a potential target for effective therapies against malignant mesothelioma? IF Nerini, E Roca, L Mannarino, F Grosso, R Frapolli, M D'Incalci Cancer Treatment Reviews 90, 102101, 2020 | 11 | 2020 |
| Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin E Bello, S Brich, I Craparotta, L Mannarino, S Ballabio, R Gatta, ... British journal of cancer 121 (6), 464-473, 2019 | 10 | 2019 |
| A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia L Mannarino, L Paracchini, I Craparotta, M Romano, S Marchini, R Gatta, ... The pharmacogenomics journal 18 (1), 56-63, 2018 | 9 | 2018 |
| Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas L Libera, I Craparotta, N Sahnane, AM Chiaravalli, L Mannarino, R Cerutti, ... Human pathology 81, 235-244, 2018 | 8 | 2018 |
| Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer L Paracchini, L Mannarino, L Beltrame, F Landoni, R Fruscio, T Grassi, ... Cancers 14 (15), 3697, 2022 | 4 | 2022 |
| Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations L Mannarino, F Mirimao, N Panini, L Paracchini, S Marchini, L Beltrame, ... Cell Death & Disease 13 (7), 612, 2022 | 4 | 2022 |
| A pan-cancer landscape of pathogenic somatic copy number variations T Becchi, L Beltrame, L Mannarino, E Calura, S Marchini, C Romualdi Journal of Biomedical Informatics 147, 104529, 2023 | 3 | 2023 |
| Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy A Salamone, G Terrone, R Di Sapia, S Balosso, T Ravizza, L Beltrame, ... Neurobiology of Disease 173, 105835, 2022 | 3 | 2022 |
| Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma L Mannarino, I Craparotta, S Ballabio, R Frapolli, M Meroni, E Bello, ... Genomics 113 (5), 3439-3448, 2021 | 3 | 2021 |
